ALXP
ALGAE
Market cap67mUSD
May 13, Last price
0.50EUR
Name
Fermentalg SA
Chart & performance
P/E
—
P/S
14.87
EPS
—
Vol. 1Y
—
Shs. 5Y
20.88%
Rev. 5Y
75.18%
Div Yld LY
—
Div Yld TTM
—
Revenues
4m
-46.94%
Net income
-14m
L+43.29%
CFO
-9m
L+5.41%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Fermentalg S.A. is a French enterprise that develops, produces, and markets active compounds derived from microalgae, serving the global food, health, and nutrition sectors. Its product lineup features DHA ORIGINS, a plant-based DHA oil; PROTEALG, a vegetable protein; and BLUE ORIGIN, a natural colorant alternative for human dietary applications. Additionally, Fermentalg offers carbon capture solutions designed to sequester CO2 in urban and industrial environments. Founded in 2009, the company is headquartered in Libourne, France.
Key people
Philippe Lavielle
Chairman of the Board · since 2023
Pierre Josselin
Chief Executive Officer, Executive Director · since 2023
Bertrand Devillers
Chief Financial Officer · since 2022
Hywel Griffiths
Chief Scientific Officer
Matthieu De Blic
Financial Controller · since 2023
Nico Bonne
Sales Director · since 2023
Marie-Jane Fallourd
Director of Marketing
Emmanuelle Benitez Cano
Director of Human Resources
Christine Bousses
Quality Director · since 2023
Sonia Da Rocha Gomes
Support Director Technique Clients · since 2023
Christian Martin
Head of Strategic Development · since 2023
Guillaume Nogaro
Director of Operations · since 2023
Rodrigo Rangel
Research and Development Director · since 2023
Gilles Schang
Director - Representative of Bpifrance Investment
Stephane Villecroze
Director - Representative of Demeter Partners
Audrey Menasse
Independent Director · since 2017
Fabienne Saadane-Oak
Independent Director · since 2017
Natalie Vallier
Independent Director · since 2023
Headquarters & legal address
4 RUE RIVIERE
LIBOURNE 33500
FR
LIBOURNE 33500
FR
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||